Life science
FDA's shame list includes 40 pharmaceutical manufacturers such as Novartis, Bayer and Pfizer, which "game the system" to block generic drug competition
Hi, what are you looking for?
Jewish Business News
All posts tagged "Mylan’"
Business
The CEO of Allergen tried to transfer ownership of the company's patents to Mohawk Indian tribe that enjoys legal immunity - but the court...
Court
The UK court ruled in favor of Mylan and its Dutch partner Synthon and canceled all of Teva's patents on Copaxone 40 mg in...
Business
The generic drugmaker expects the new Israeli facility to generate $100 million in revenue annually.
Business
6% workforce reduction, $2 billion in stock repurchases and vitamin unit sale in the offing
Business
The hostile takeover bid for Perrigo Co. PLC continues with Mylan NV hosting a Tuesday, 5 pm, conference call to pitch the buyout...
Business
The Generic-drug maker took its bid directly to shareholders after being rebuffed since April
Business
Joseph Papa scathingly dismisses Mylan's latest tactic in lowering the stake it wants to buy in Perrigo. "today's announcement makes it even worse"
Business
Mylan could settle for buying control of Perrigo, rather than full ownership, keeping Perrigo listed on the TASE.
Business
Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.